{"id":"W2073051283","doi":"10.1503/cmaj.109-4483","title":"US approves “new class” of diabetes drug, under review in Canada","year":2013,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Food and drug administration; Drug; Medicine; New drug application; Drug class; Drug approval; Type 2 diabetes; Brand names; Pharmacology; Diabetes mellitus; Corporation; Family medicine; Business; Advertising; Finance","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002060461,0.000451859,0.000625491,0.001372105,0.003153185,0.003167775,0.001175825,0.00347825,0.009659254],"category_scores_gemma":[0.005185416,0.0002225124,0.0007445425,0.001977498,0.001034541,0.0007237552,0.0004742744,0.002364374,0.001576446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01806632,"about_ca_system_score_gemma":0.1623887,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8004943,"about_ca_topic_score_gemma":0.9357698,"domain_scores_codex":[0.9970156,0.0001990627,0.0001177137,0.0001789536,0.00194759,0.000541239],"domain_scores_gemma":[0.9884538,0.0004069006,0.0003471386,0.00009985498,0.008434779,0.002257497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003625754,0.0001390008,0.003278185,0.0005916355,0.00008638456,0.0008829937,0.00008330585,0.0002248565,0.001321647,0.004621796,0.8538973,0.1345104],"study_design_scores_gemma":[0.0003575555,0.0001661917,0.006893382,0.0004636433,0.0001035563,0.0003223224,0.0000918625,0.0001974055,0.0006764998,0.000305485,0.990398,0.00002405478],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"commentary","genre_scores_codex":[0.02938576,0.2315442,0.001773824,0.2435499,0.0318094,0.001755749,0.009927243,0.0006746769,0.4495793],"genre_scores_gemma":[0.236517,0.2685636,0.006320335,0.1695587,0.009968415,0.0005897832,0.008888373,0.0002628361,0.2993309],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.1995057,"threshold_uncertainty_score":0.4013613,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09060652290539085,"score_gpt":0.3219911184264076,"score_spread":0.2313845955210168,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}